Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions Ltd

₹ 1,575 0.90%
21 May 2:05 p.m.
About

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Key Points

Business Overview:[1]
IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health care organizations, enabling them to deliver superior clinical care through a **fee for value model **

  • Market Cap 27,022 Cr.
  • Current Price 1,575
  • High / Low 2,190 / 1,226
  • Stock P/E 55.5
  • Book Value 104
  • Dividend Yield 0.00 %
  • ROCE 27.2 %
  • ROE 33.0 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 28.8% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 37.0%

Cons

  • Stock is trading at 15.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025
567 620 643 657 724
405 494 454 476 498
Operating Profit 162 126 189 181 226
OPM % 29% 20% 29% 28% 31%
6 15 5 27 3
Interest 26 32 22 21 21
Depreciation 19 27 28 28 28
Profit before tax 124 81 144 160 180
Tax % 18% 21% 21% 19% 18%
102 64 113 130 148
EPS in Rs 5.94 3.72 6.59 7.56 8.61
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
529 553 764 1,031 1,818 2,664
367 348 466 639 1,297 1,894
Operating Profit 162 205 298 392 521 770
OPM % 31% 37% 39% 38% 29% 29%
31 16 1 -2 40 39
Interest 7 8 7 6 61 90
Depreciation 40 30 23 25 59 113
Profit before tax 145 183 269 359 442 606
Tax % 5% 9% 13% 15% 16% 20%
137 165 233 305 370 486
EPS in Rs 166.73 200.10 13.61 17.86 21.68 28.33
Dividend Payout % 0% 12% 393% 0% 46% 0%
Compounded Sales Growth
10 Years: %
5 Years: 38%
3 Years: 52%
TTM: 47%
Compounded Profit Growth
10 Years: %
5 Years: 29%
3 Years: 25%
TTM: 31%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 39%
3 Years: 37%
Last Year: 33%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 17 17 17 17
Reserves 275 449 630 812 1,141 1,773
0 76 65 52 1,311 856
151 53 75 107 411 407
Total Liabilities 434 586 788 988 2,880 3,052
36 87 76 59 1,833 1,798
CWIP 0 0 0 0 3 5
Investments 1 14 16 32 195 114
397 485 695 898 849 1,135
Total Assets 434 586 788 988 2,880 3,052

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
163 175 233 288 210 318
-79 -167 -82 -158 -1,137 244
-41 -37 -59 -152 780 -389
Net Cash Flow 43 -28 92 -22 -147 173

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 51 49 46 57 73 73
Inventory Days
Days Payable
Cash Conversion Cycle 51 49 46 57 73 73
Working Capital Days 20 48 21 26 6 46
ROCE % 47% 47% 50% 30% 27%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2024Mar 2025
63.72% 63.72%
5.48% 5.38%
4.45% 4.02%
23.52% 24.29%
2.85% 2.58%
No. of Shareholders 67,58357,714

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents